X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2539) 2539
Book Review (607) 607
Magazine Article (251) 251
Publication (133) 133
Book Chapter (22) 22
Trade Publication Article (19) 19
Conference Proceeding (15) 15
Book / eBook (11) 11
Government Document (9) 9
Newsletter (8) 8
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1977) 1977
humans (1801) 1801
ophthalmology (1377) 1377
female (1073) 1073
male (994) 994
dry eye (920) 920
dry eye syndromes - drug therapy (917) 917
middle aged (781) 781
adult (651) 651
eye diseases (592) 592
dry eye syndromes (544) 544
aged (543) 543
care and treatment (435) 435
animals (426) 426
treatment outcome (375) 375
ocular surface (364) 364
disease (346) 346
ophthalmic solutions (321) 321
dry eye syndromes - diagnosis (319) 319
keratoconjunctivitis sicca (313) 313
dry eye disease (295) 295
inflammation (287) 287
cornea (285) 285
dry eye syndromes - metabolism (278) 278
dry eye syndromes - etiology (272) 272
prevalence (266) 266
prospective studies (264) 264
ophthalmic solutions - administration & dosage (261) 261
research (251) 251
sense organs (251) 251
diagnosis (248) 248
dry eye syndromes - physiopathology (246) 246
drug therapy (243) 243
dry eye syndrome (223) 223
tears - metabolism (222) 222
aged, 80 and over (217) 217
ophthalmic solutions - therapeutic use (217) 217
health aspects (215) 215
ophthalmic drugs (213) 213
administration, topical (211) 211
pharmacology & pharmacy (211) 211
analysis (203) 203
sjogrens-syndrome (202) 202
eye (200) 200
dry eye syndromes - therapy (180) 180
tear film (179) 179
symptoms (178) 178
surveys and questionnaires (177) 177
dry eye syndromes - pathology (175) 175
genetic structures (175) 175
disease models, animal (174) 174
efficacy (173) 173
risk factors (172) 172
young adult (172) 172
double-blind method (167) 167
tears - chemistry (166) 166
patients (160) 160
tears (155) 155
cyclosporine (152) 152
meibomian gland dysfunction (151) 151
mice (151) 151
tears - physiology (141) 141
usage (141) 141
therapy (139) 139
surgery (137) 137
follow-up studies (136) 136
adolescent (132) 132
medicine & public health (132) 132
dosage and administration (130) 130
artificial tears (129) 129
glaucoma (129) 129
ocular surface disease (129) 129
cyclosporine - administration & dosage (128) 128
fluorescein (128) 128
sjogren's syndrome (128) 128
cornea - drug effects (126) 126
cornea - pathology (126) 126
quality of life (124) 124
subcommittee (121) 121
expression (118) 118
abridged index medicus (117) 117
workshop 2007 (114) 114
medicine (112) 112
conjunctiva - pathology (109) 109
safety (108) 108
lacrimal gland (107) 107
immunosuppressive agents - administration & dosage (106) 106
medical research (105) 105
retrospective studies (105) 105
dry eye syndromes - chemically induced (104) 104
cytokines (102) 102
clinical trials (101) 101
conjunctiva (99) 99
research article (99) 99
studies (99) 99
tears - secretion (98) 98
cornea - metabolism (96) 96
cyclosporine - therapeutic use (94) 94
article (93) 93
conjunctiva - drug effects (93) 93
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2670) 2670
German (44) 44
French (24) 24
Russian (19) 19
Spanish (14) 14
Chinese (12) 12
Polish (11) 11
Japanese (10) 10
Romanian (7) 7
Korean (6) 6
Portuguese (6) 6
Turkish (3) 3
Croatian (1) 1
Dutch (1) 1
Finnish (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 09/2015, Volume 213, pp. 168 - 174
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 2018, Volume 13, pp. 7251 - 7273
Introduction: Dry-eye syndrome (DES) is a general eye disease. Eye drops are the common ophthalmological medication. However, the ocular barrier makes it... 
Epigallocatechin gallate | DES | EGCG | Dry-eye syndrome | Gelatin nanoparticles | Hyaluronic acid | Anti-inflammation | CELLS | epigallocatechin gallate | dry-eye syndrome | NANOSCIENCE & NANOTECHNOLOGY | anti-inflammation | CHITOSAN NANOPARTICLES | OCULAR DRUG-DELIVERY | MODEL | hyaluronic acid | SOLID LIPID NANOPARTICLES | THERAPEUTIC-EFFICACY | IN-VIVO | DISEASE | SURFACE | PHARMACOLOGY & PHARMACY | gelatin nanoparticles | Ophthalmic Solutions - pharmacology | Nanoparticles - chemistry | Epithelial Cells - drug effects | Humans | Male | Epithelium, Corneal - pathology | Dry Eye Syndromes - pathology | Inflammation - drug therapy | Catechin - therapeutic use | Catechin - pharmacology | Gelatin - chemistry | Disease Models, Animal | Cell Survival - drug effects | Rabbits | Cytokines - metabolism | Dry Eye Syndromes - drug therapy | Ophthalmic Solutions - therapeutic use | Hyaluronic Acid - chemistry | Nanoparticles - ultrastructure | Rats | Treatment Outcome | Particle Size | Animals | Catechin - analogs & derivatives | Sus scrofa | Tears | Ethylenediaminetetraacetic acid | Nanoparticles | Catechin | Analysis | Ophthalmic drugs | Neomycin | Fluorescein | Eye diseases | Inflammation | Gene expression | Transdermal medication | Drugs | Cornea | Cytokines | Bioavailability | Retention | Molecular weight | Medicine | Engineering | Polyphenols | Laboratory animals | Biomedical engineering | Index Medicus | Dry eye syndrome (DES) | Epigallocatechin gallate (EGCG) | Hyaluronic acid (HA)
Journal Article
Journal Article
Journal Article